<VariationArchive RecordType="classified" VariationID="3300" VariationName="NM_000268.4(NF2):c.205_211del (p.Lys69fs)" VariationType="Deletion" Accession="VCV000003300" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2013-04-04" MostRecentSubmission="2023-07-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18339" VariationID="3300">
      <GeneList>
        <Gene Symbol="NF2" FullName="NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor" GeneID="4771" HGNC_ID="HGNC:7773" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29603556" stop="29698600" display_start="29603556" display_stop="29698600" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29999544" stop="30094588" display_start="29999544" display_stop="30094588" Strand="+" />
          </Location>
          <OMIM>607379</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NF2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000268.4(NF2):c.205_211del (p.Lys69fs)</Name>
      <CanonicalSPDI>NC_000022.11:29636840:AAGGACA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29636841" stop="29636847" display_start="29636841" display_stop="29636847" variantLength="7" positionVCF="29636840" referenceAlleleVCF="CAAGGACA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="30032830" stop="30032836" display_start="30032830" display_stop="30032836" variantLength="7" positionVCF="30032829" referenceAlleleVCF="CAAGGACA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.30032830_30032836del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.30032830_30032836del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.29636841_29636847del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.29636841_29636847del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009057.1" sequenceAccession="NG_009057" sequenceVersion="1" change="g.38286_38292del">
            <Expression>NG_009057.1:g.38286_38292del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181829.3" sequenceAccession="NM_181829" sequenceVersion="3" change="c.205_211del">
            <Expression>NM_181829.3:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861967.1" sequenceAccession="NP_861967" sequenceVersion="1" change="p.Lys69fs">
            <Expression>NP_861967.1:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181832.3" sequenceAccession="NM_181832" sequenceVersion="3" change="c.205_211del">
            <Expression>NM_181832.3:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861970.1" sequenceAccession="NP_861970" sequenceVersion="1" change="p.Lys69fs">
            <Expression>NP_861970.1:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181833.3" sequenceAccession="NM_181833" sequenceVersion="3" change="c.205_211del">
            <Expression>NM_181833.3:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861971.1" sequenceAccession="NP_861971" sequenceVersion="1" change="p.Lys69fs">
            <Expression>NP_861971.1:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_156186.2" sequenceAccession="NR_156186" sequenceVersion="2" change="n.687_693del">
            <Expression>NR_156186.2:n.687_693del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181828.3" sequenceAccession="NM_181828" sequenceVersion="3" change="c.115-2249_115-2243del">
            <Expression>NM_181828.3:c.115-2249_115-2243del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181830.3" sequenceAccession="NM_181830" sequenceVersion="3" change="c.115-5361_115-5355del">
            <Expression>NM_181830.3:c.115-5361_115-5355del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181831.3" sequenceAccession="NM_181831" sequenceVersion="3" change="c.115-5361_115-5355del">
            <Expression>NM_181831.3:c.115-5361_115-5355del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000268.4" sequenceAccession="NM_000268" sequenceVersion="4" change="c.205_211del" MANESelect="true">
            <Expression>NM_000268.4:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000259.1" sequenceAccession="NP_000259" sequenceVersion="1" change="p.Lys69fs">
            <Expression>NP_000259.1:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016418.5" sequenceAccession="NM_016418" sequenceVersion="5" change="c.205_211del">
            <Expression>NM_016418.5:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057502.2" sequenceAccession="NP_057502" sequenceVersion="2" change="p.Lys69fs">
            <Expression>NP_057502.2:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181825.3" sequenceAccession="NM_181825" sequenceVersion="3" change="c.205_211del">
            <Expression>NM_181825.3:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861546.1" sequenceAccession="NP_861546" sequenceVersion="1" change="p.Lys69fs">
            <Expression>NP_861546.1:p.Lys69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_511" sequenceAccession="LRG_511">
            <Expression>LRG_511:g.38286_38292del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t1" sequenceAccession="LRG_511t1">
            <Expression>LRG_511t1:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_511p1" sequenceAccession="LRG_511p1" change="p.Lys69fs">
            <Expression>LRG_511p1:p.Lys69fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_511t2" sequenceAccession="LRG_511t2">
            <Expression>LRG_511t2:c.205_211del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_511p2" sequenceAccession="LRG_511p2" change="p.Lys69fs">
            <Expression>LRG_511p2:p.Lys69fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA021412" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607379.0019" DB="OMIM" />
        <XRef Type="rs" ID="587776565" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000268.4(NF2):c.205_211del (p.Lys69fs) AND Schwannomatosis 1" Accession="RCV000003461" Version="5">
        <ClassifiedConditionList TraitSetID="2182">
          <ClassifiedCondition DB="MedGen" ID="C4048809">Schwannomatosis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2023-07-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9399891</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2182" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Schwannomatosis 1</ElementValue>
                <XRef ID="MONDO:0024517" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurilemmomatosis congenital cutaneous</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SWN1</ElementValue>
                <XRef Type="MIM" ID="162091" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with SMARCB1-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a SMARCB1 pathogenic variant.</Attribute>
                <XRef ID="NBK487394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000335543" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551659" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000335548" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528885" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552308" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552305" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552477" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000309827" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552306" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576339" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29517885</ID>
                <ID Source="BookShelf">NBK487394</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2020">
                <ID Source="PubMed">32602153</ID>
              </Citation>
              <XRef ID="93921" DB="Orphanet" />
              <XRef ID="C4048809" DB="MedGen" />
              <XRef ID="MONDO:0024517" DB="MONDO" />
              <XRef Type="MIM" ID="162091" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23619" SubmissionDate="2013-03-14" DateLastUpdated="2023-07-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607379.0019_SHWANNOMATOSIS, SOMATIC" title="NF2, 7-BP DEL, NT105_SHWANNOMATOSIS, SOMATIC" />
        <ClinVarAccession Accession="SCV000023619" DateUpdated="2023-07-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with neurilemmomatosis (see 101000), a 52-year-old man with bilateral multiple schwannomas in the legs (pain in the left leg began at the age of 45 years), Jacoby et al. (1997) found deletion of nucleotides 205 to 211 in exon 2 of the NF2 gene. This produced a frameshift beginning at lysine-69 and leading to premature termination at codon 122. The mutation was somatic in origin inasmuch as other body cells did not show the mutation. This was despite the fact that the father and a niece were said to be affected also. Two other tumors showed different somatic mutations in NF2, a frameshift mutation in exon 5 and a frameshift mutation in exon 2. Loss of heterozygosity for markers in the region of chromosome 22 surrounding the NF2 gene was found in all 3 tumors. This and similar findings in other cases suggested to Jacoby et al. (1997) the existence of an inherited predisposition to the formation of tumors that carry somatic alterations of the NF2 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">9399891</ID>
              </Citation>
              <XRef DB="OMIM" ID="101000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NF2" />
          </GeneList>
          <Name>NF2, 7-BP DEL, NT105</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">7-BP DEL, NT105</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607379.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SHWANNOMATOSIS, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

